Cbln1 is the prototype of a family (Cbln1-Cbln4) of secreted glycoproteins and is essential for normal synapse structure and function in cerebellum by bridging presynaptic Nrxn to postsynaptic Grid2. Here we report the effects of glycosylation on the in vitro receptor binding properties of Cblns. Cbln1, 2 and 4 harbor two N-linked glycosylation sites, one at the Nterminus is in a region implicated in Nrxn binding and the second is in the C1q domain, a region involved in Grid2 binding. Mutation (asparagine to glutamine) of the N-terminal site, increased neurexin binding whereas mutation of the C1q site markedly increased Grid2 binding. These mutations did not influence subunit composition of Cbln trimeric complexes (mediated through the C1q domain) nor their assembly into hexamers (mediated by the N-terminal region).
pI, isoelectric points; qPCR, quantitative PCR; PCR, polymerase chain reaction; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis. WT, wild type.
Introduction
Cbln1 is a member of the C1q/TNF superfamily of proteins (Urade et al., 1991; Bao et al., 2005) and its genetic elimination in mice leads to ataxia due to a loss of synaptic connectivity between cerebellar granule neurons and Purkinje cells (Hirai et al., 2005) . Cbln1and its three immediate family members, Cbln2-Cbln4 are secreted as hexameric complexes composed of a dimer of trimers, wherein the C1q domain in the C-terminal half of the protein mediates trimer assembly and a cysteine motif near the N-terminus supports dimerization of trimers via intermolecular disulfide bonding . Functionally, Cbln1 hexamers behave as bivalent ligands that participate in a trans-synaptic complex that bridges presynaptic Neurexins in granule neurons to post-synaptic Grid2 in Purkinje neurons (Matsuda et al., 2010; Uemura et al., 2010; Elegheert et al., 2016; Cheng et al., 2016) . Structural studies have revealed that the N-terminal region of Cbln1 is involved in Nrxn binding whereas Grid2 binding is largely mediated by the C1q domain (Elegheert et al., 2016; Cheng et al., 2016) .
Besides their hexameric configuration another cardinal feature of the Cblns is the presence of two conserved N-linked glycosylation sites. One is at the N-terminus, the region implicated in Nrxn binding (Elegheert et al., 2016; Cheng et al., 2016) and dimerization ) and the second is in the C1q domain, the region that mediates both Grid2 binding (Elegheert et al., 2016; Cheng et al., 2016; Zhong et al., 2017) and trimerization of Cbln protomers . In several C1q/TNF superfamily members, such as complement component C1q (Ritchie et al., 2002) and the cytokine TNFα glycosylation influences biological activity (Koyama et al., 1992) . As the glycosylation sites in Cblns are located in the regions implicated in receptor interactions and subunit assembly we addressed the questions of whether glycosylation of the Cblns affected their receptor binding properties or influenced the structure and composition of their complexes. We also sought to assess whether glycosylation contributed to the unique binding of Cbln4 to deleted in colon cancer (DCC) or influenced the dependence of Cbln binding on the presence of the S4 splice region in neurexins. We demonstrate that glycosylation of Cblns markedly and selectively attenuates their receptor binding in vitro without altering the subunit composition or stoichiometry of Cbln complexes.
Furthermore, ectopically expressed Cbln4 glycosylation mutants in vivo are more potent than wild type Cbln4 in rescuing ataxia in Cbln1-null mice. These gain-of-function molecules can be valuable tools in dissection the burgeoning examples of extra-cerebellar functions of Cblns.
Results
The Cblns are glycosylated at asparagine residues: Cbln1 N23, N79; Cbln2 N53, N110; Cbln3 N82; Cbln4 N26, N85. One glycosylation site is at the N-terminus (Cbln3 lacks this site) [Fig. 1a] , whereas the second is in the αA helix within the C1q domain (Elegheert et al., 2016) [Fig. 1a] . Since Cbln3 is not secreted , we tested monoglycosylation mutants of Cbln1, Cbln2 and Cbln4 for secretion. All single mutants were secreted [Fig. 1b] . Furthermore PNGase F digestion of WT or monoglycosylation mutants generated an ~20 kDa band, corresponding to the calculated mass of the non-glycosylated proteins [Fig. 1b] . Untreated Cbln2-N53Q, Cbln4-N26Q and Cbln4-N85Q display an additional weak upper band approximately the same size as the untreated wildtype forms [Fig. 1b] . These bands disappear upon PNGase F treatment [Fig. 1b] . These bands may represent a very minor population of Cbln proteins with higher mass glycan chains, although their true identity is unknown and are not seen in double glycosylation site mutants [ Fig. 1b Cbln1 and Cbln4 interact with Nrxns via a 30 amino acid long splice segment (so-called S4 region) (Joo et al., 2011; Wei et al., 2012) . We investigated whether the monoglycosylation mutants retained their dependence on the S4 domain. Neither WT nor monoglycosylation mutants of Cbln1 [ Fig. 3a] , Cbln2 [Fig. 3b] or Cbln4 [ Fig. 3c ] bound with S4-deleted (∆S4) variants of Nrxn1β or Nrxn3β.
DCC belongs to a family of related receptors implicated in developmental processes (Mehlen et al., 1998; Jiang et al., 2003; Mehlen et al., 2007; Castets et al., 2012) . We showed Cbln4 associates with DCC ) and a subsequent report (Haddick et al., 2014) The carbohydrate chains of glycoproteins are frequently capped by negatively charged sialic acid residues (Varki et al., 2009) , and sialylation can interfere with receptor ligand interactions (Quast et al., 2015) . When cerebellar extracts were subjected to two dimensional gel electrophoresis (2DGE) and immunoblotted with anti-Cbln1 antiserum, multiple spots of Cbln1-like ir were evident [ Fig. 4a ]. Five of these spots, of the same molecular weight, but disparate isoelectric points (pI), were deemed specific based upon their absence in extracts from Cbln1-null cerebellum and known enhanced expression in Cbln3-null cerebellum [circles, Fig. 4a ] (Bao et al., 2006) .
Two of the spots were more acidic than the predicted pI of Cbln1 (pI=5.9). To determine whether the charge heterogeneity of Cbln1 was attributable to sialic acid, HA-Cbln1 was digested with neuraminidase and run on 2DGE IB [ Fig. 4b ]. Untreated HA-Cbln1 ran as at least 7 spots of the same molecular weight and pI more acidic than the predicted pI of HA-Cbln1 (pI=5.23) [Fig 6b] . As Cbln4 uniquely binds DCC and monoglycosylated Cbln4 gains Grid2 binding, we examined whether neuraminidase treatment affects these parameters. 2DGE IB of recombinant HA-Cbln4 reveal numerous poorly resolved spots of similar molecular weights [ Fig.5a ]. The majority of spots are more acidic than the predicted pI of HA-Cbln4 (pI=5.9). Treatment with neuraminidase eliminates the most acidic spots [ Fig. 5a ] without affecting molecular weight [ Fig. 5a ,b].
However, neuraminidase treatment did not uncover Grid2 binding [ Fig. 5b ].
Carbohydrate chains on proteins create distinct structural elements that can influence interactions with other molecules (Hanson et al., 2009; Nyathi et al., 2013) . Secreted Cblns are homo-and heteromeric complexes composed of six subunits, assembled into a dimer of trimers The size of Cbln-containing complexes can be investigated by native gel electrophoresis . WT Cbln1, Cbln2 or Cbln4-containing complexes behave as hexamers [Fig. 7a upper panel] . Glycosylation mutants also behaved as hexamers with only Cbln4 N26Q favoring production of a larger complex [ Fig. 7a ]. Thus, glycosylation does not markedly affect the formation or composition of hexameric complexes.
Glycosylation site mutants were obtained by mutating asparagine to glutamine and so the possibility exists that this amino acid change alone rather than loss of the glycan results in enhanced binding. To address this concern, we generated unglycosylated or partially glycosylated forms of Cbln4 by inhibition of N-linked glycan synthesis using tunicamycin (Elbein AD, 1987) . Tunicamycin showed concentration dependent glycosylation changes on Cbln4, resulting in secretion of mono or unglycosylated forms of the protein (Fig 7b) .
Unglycosylated and partially glycosylated Cbln4 from tunicamycin treated cells bound to Nrxn1, Grid2 and DCC to a much greater extent than fully glycosylated Cbln4 (Fig 7b) .
These data are consistent with the results obtained using asparagine to glutamine mutant Cbln4 (Fig 2) and reinforce our hypothesis that glycans are inhibitory to the binding of Cblns with its receptors.
Targeted expression of Cbln1 or Cbln2 in Purkinje neurons of transgenic mice using the Purkinje cell-specific L7-promoter (Oberdick et al., 1990) prevents cerebellar deficits in Cbln1-null mice . As glycosylation mutants of Cbln4 bind Grid2 in vitro we hypothesized they would rescue Cbln1 deficiency in vivo and tested this using the same L7 promoter-based strategy The relative levels of mRNA expression in different transgenic lines was measured by Northern blotting of total cerebellar RNA with an L7 probe that detects endogenous L7 mRNA (internal loading control) and the common component of larger L7-Cbln1, L7-Cbln2, L7-Cbln4, L7-Cbln4 N26Q and L7-Cbln4 N85Q fusion mRNAs [ Fig. 8c ]. This permitted quantitative comparison of mRNA levels in multiple L7-Cbln4 transgenic lines and comparison to levels of mRNA for L7-Cbln1 and L7-Cbln2 in the two strains of transgenic mice that rescue function in Cbln1-null mice . The mRNA level in L7-Cbln4 was similar to the L7-Cbln1 line, but less than the L7-Cbln2 line [ Fig. 8c ]. The expression levels of L7-Cbln4 N26Q and L7-Cbln4 N85Q mRNAs
were lower than those of L7-Cbln1, L7-Cbln2 and L7-Cbln4 [ Fig. 8c ].
To ensure expression of L7-Cbln4 mRNAs reflected Cbln4 protein levels, and that expression was confined to Purkinje cells, Cbln4 immunohistochemistry was performed. Cbln4-like immunoreactivity (ir) was not detectable in cerebellum of non-transgenic mice [Fig. 8d(i, v) ]. In contrast, punctate Cbln4-like ir was observed in Purkinje cells, but not other cerebellar neurons,
The punctate staining is similar to that in L7-Cbln1 and L7-Cbln2 mice , 
Discussion
The present study establishes that the N-linked carbohydrate chains of Cbln1, 2 and 4 impair receptor binding in vitro. This phenomenon is domain and receptor-dependent. Elimination of the N-terminal N-glycan in Cbln1, Cbln2 and Cbln4 enhances Nrxn binding [ Fig. 2 ], which interacts with this region, and has a lesser potentiating effect on Grid2 binding that involves the C1q domain (Elegheert et al., 2016; Cheng et al., 2016) . In contrast, Cbln1 and Cbln2 binding to Grid2 is greatly enhanced by elimination of their C1q glycosylation sites with lesser effects on Nrxn binding. In the case of Cbln4, mutation of its C1q glycosylation site enhances its known DCC binding and uncovers potent cryptic Grid2 binding that could explain its ability to rescue Cbln1 loss of function in vivo. The attenuation of Cbln binding and activity by glycosylation is reminiscent of the action of glycosylation in TNFα. This cytokine is structurally similar to Cblns, and its glycosylation limits its biological activity (Koyama et al., 1992) .
A key question is how glycosylation of the ligand influences its receptor binding. One possibility is that N-glycans alter subunit stoichiometry of the secreted complexes. For example, if reduced glycosylation changed the complex from a hexamer (dimer of trimers) to a dodecamer (tetramer of trimers), thereby potentially doubling the number of receptor binding interfaces, the ligand binding affinity should increase exponentially. As Cbln complexes withstand native gel electrophoresis, this is used to assess their apparent molecular mass (Quast et al., 2015) . suggesting a larger segment of the glycan, if not its entirety is required to impair binding.
Therefore, the carbohydrates must either interact with the amino acid backbone of the monomer to influence its 3D structure and thereby receptor binding or the carbohydrates could physically overlie the receptor-binding domain and impair binding via steric hindrance.
Cbln proteins belong to the C1q/TNF superfamily. The 3-D structure of the C-terminal globular domain of human C1q was determined by X-ray crystallography (Gaboriaud et al., 2003) and is a globular, almost spherical heterotrimeric assembly, with the N-and C-termini of each subunit emerging at the base of the trimer. Each subunit exhibits a 10-stranded β sandwich fold with a jelly roll topology homologous to that described initially for tumor necrosis factor (Eck et al., 1989) . Comparison of the C1q/TNF superfamily indicates strong conservation of the β-strands but variability in the loops connecting them (Ressl et al., 2015) . The recent Cbln1-Grid2 structural analysis shows that the Cbln1 C1q domain binds the Grid2 extracellular aminoterminal domain via loops AA', CD, EF, and GH from one C1q subunit [ Fig. 1a ] (Elegheert et al., 2016; Cheng et al., 2016) . Cbln1 residues Thr70, Asn71, His72 of loop AA' and Lys181 of loop GH form a putative hydrogen-bonding network to Grid2 at residue Asp24. The Cbln1 C1q domain N-glycosylation site (Asn79) is located on the αA helix within loop AA' [Fig. 1a] . The αA helix is a unique structural element of the Cbln family, with no other C1q structures containing these αA helices (Zhong et al., 2017) . The C1q domain N-glycan modification could interfere with the ligand-receptor binding interface within loop AA'. Alternatively, or in addition, it might affect the three dimensional configuration of Cblns, potentially by promoting the αA helix, and thereby modifying binding to Grid2. In this scenario distortion of the protomer structure around the Grid2 binding site would reduce ligand affinity. By comparing crystal structures of the C1q domains of Cbln1 and Cbln4, Zhong et al., (2017) hypothesized that loop CD divergence could account for the inability of Cbln4 to bind with Grid2. The structures of Cbln1 or Cbln4 obtained by Elegheert et al., (2016 ), Cheng et al., (2016 and Zhong et al., (2017) all used glycosylated proteins to define the Cbln-Grid2 interface. There is no data published to date of the structure of monoglycosylated Cblns and the affect these modifications have on CblnNrxns or Cbln-Grid1/2 complexes. Therefore, our data might prompt an exploration of this subject and may permit precise biophysical measurements of ligand-Grid2 affinities which have been elusive to date due to their weak interactions.
There are increasing examples of extracerebellar synaptic and behavioral functions of Cblns (Kusnoor et al., 2010; Otsuka et al., 2016; Krishnan et al., 2017; Zhang et al., 2017) . However, the mechanisms underlying these phenomena are less understood. Therefore, our demonstration that glycosylation mutants of Cblns are more active than their WT counterparts in vivo and in vitro could be utilized to develop tools to dissect these extracerebellar phenotypes.
Experimental procedures

Animals
WT FVB/NJ and C57BL/6J mice were obtained from Jackson Laboratory (Bar Harbor, ME 
Generation of L7-Cbln transgenic mice
L7-Cbln transgenic mice were generated as described previously (Oberdick et al., 1990; . Mice were genotyped by polymerase chain reaction (PCR) using the primers: L7-Cbln4 (F) 5′-TGA GCC TCA TGT TGA ACG GG-3′, L7-Cbln4 (R) 5′-ATG ATG ATC CCT TGG AGT-3′. Relative expression of transgenes was determined by northern blotting . Strains with the highest expression were mated with Cbln1 +/− mice to generate appropriate genotypes for analysis.
Transgene copy number measurement
Genomic DNA was isolated using the DNeasy Tissue kit (Qiagen, Valencia, CA) and L7 transgene copy number determined by quantitative real-time PCR (qPCR). Mouse-specific TaqMan Copy Number Assays for Pcp2 (L7) and Cbln3 (known copy number control) were purchased from Thermo Fisher Scientific (Waltham, MA, Pcp2, Mm00260051_cn; Cbln3, Mm00605149_cn). qPCR was performed using 2x TaqMan Fast Reagents Starter Kit and the ABI 7900 Fast Real-Time PCR system (Thermo Fisher Scientific). PCR conditions were: uracil-N-glycosylase incubation, 50˚C for 2 min, AmpliTaq Gold activation, 95°C for 10 min, denaturation 95°C for 15 s, annealing 60°C for 1 min (40 cycles).
Plasmids and constructs
Full-length murine N-terminal hemagglutinin (HA)-tagged Cbln1, Cbln2, Cbln3, and Cbln4 Wei et al., 2012) were sub-cloned into pcDNA3.1 vector (Thermo Fisher Scientific) as the backbones for mutagenesis. Myc-tagged Cbln1 and Cbln4 were generated similarly. Full-length FLAG-tagged murine Grid1, Grid2, Nrxn1β, Nrxn1β S4 -, Nrxn3β, Nrxn3β S4 -, neogenin 1 (Neo1), Igdcc3, Igdcc4, Prtg and human DCC were sub-cloned into p3XFLAG-CMV™-14 Expression Vector (Sigma-Aldrich, St. Louis, MO) . Mutations were generated using the QuikChange II XL site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA).
Deglycosylation
Conditioned medium containing WT or glycosylation mutants of HA-Cbln1, HA-Cbln2 or HACbln4 (50 µl) were digested with PNGase F (New England Biolabs, Ipswich, MA) as described previously (Hirai et al., 2005) .
In vitro binding assay
The binding of WT and glycosylation mutants of Cblns to Grid1, Grid2, Nrxn1β, Nrxn1βS4 Chicago, IL) and immunoreactive bands were detected using a chemiluminescence system (Thermo Fisher Scientific). Signals were captured using an Odyssey Fc Imaging System (LI-COR Biosciences, Lincoln, NE). Band intensities were quantified using Image Studio (LI-COR Biosciences). For quantification, band intensities for 3 separate experiments were corrected for input and analyzed by Student's t-test.
Two dimensional gel electrophoresis (2DGE)
Cerebellar P2 fractions (Gray and Whittaker 1962) or conditioned medium from HEK293T cells (PRID: CRL-3216) (ATCC, Manassas, VA) expressing Cblns were precipitated with TCA.
Pellets were suspended in 200 µl of rehydration buffer (Bio-Rad). Isoelectric focusing was performed on 11 cm immobilized pH 4-7 or pH 5-8 gradient ReadyStrip IPG strips (Bio-Rad).
Second dimensional gel electrophoresis was performed using Bio-Rad's 4-12% Criterion XT Bis-Tris precast polyacrylamide gels. Proteins were transferred to nitrocellulose membranes (0.2 microns) using iBlot semi-dry transfer conditions (Thermo Fisher Scientific), and IB performed using anti-HA antibodies (RRID: AB_2565335) or rabbit antibodies against Cbln1 .
Desialylation
Conditioned medium from HEK293T cells expressing HA tagged proteins was incubated with
GlycoCleave neuraminidase absorbent beads (GALAB Technologies GmbH, Germany), heatinactivated beads (95ºC 10 min) or no beads at 37ºC for 3 h or 18 h for Cbln1 and 6 h for Cbln4.
2DGE IB was also performed on Cbln1 and Cbln4 samples to confirm removal of sialic acid.
Co-immunoprecipitation (IP)
Conditioned medium from HEK293T cells expressing combinations of Myc and HA epitope containing proteins was collected after 48 h of transfection and was spun down at 5000 rpm for 5 min to remove any cells or cell debris. Medium was concentrated 4 times using 3000 MWCO 
Native gel electrophoresis
Conditioned medium from HEK293T cells expressing HA-tagged WT or mutant Cblns was mixed with an equal volume of native sample buffer (Bio-Rad). Samples were separated on precast 7.5% Tris-HCl Criterion gels (Bio-Rad), transferred onto nitrocellulose membranes, immunoblotted using anti-HA antibody and signal visualized by chemiluminescence (Thermo Fisher Scientific). Native protein standards (Thermo Fisher Scientific) were run on independent gels and stained with SYPRO Ruby Protein Gel Stain (Sigma-Aldrich) and visualized by ultra violet light using a Gel Doc system (Alpha Innotech, San Leandro, CA).
Tunicamycin assay
HEK293T cells were transfected with vectors carrying HA epitope tagged Cbln4 in six well plates. After 4 hours of transfection, HEK293T cells were exposed to different concentrations of tunicamycin (Sigma-Aldrich) for 42 hours. Conditioned media containing secreted proteins was collected and centrifuged at 2000 rpm for 5 min to remove any cell debris. Clear supernatant containing secreted HA-Cbln4 was added to HEK293T cells expressing one of FLAG-tagged Nrxn1, DCC or Grid2 in a binding assay as described in section 4.6 above.
Histologic methods
Three-month-old mice were anesthetized and perfused transcardially with buffered 4%
paraformaldehyde and the brains were removed and processed for paraffin-embedding as described previously (Wei et al., 2007) . 5-µm sagittal sections were stained with hematoxylin and eosin for standard histological analysis. For immunohistochemistry, sections were subjected to heat-mediated antigen retrieval in 0.01 M sodium citrate buffer (pH 6.0) containing 0.05%
Tween 20 (Sigma-Aldrich) as described (Wei et al., 2009) . Immunostaining for Cbln4 was performed using rabbit anti-Cbln4 (1:300, Aviva Systems Biology, San Diego, CA).
Immunocomplexes were revealed using a peroxidase-conjugated anti-rabbit antiserum and diaminobenzidine tetrahydrochloride (DAB) substrate (Dako, Carpenteria, CA).
Rotarod test
Mice were randomly assigned to different cages (1-5/cage) when they were 21-days old. The mice (20-30 g/mouse; 45-50 days old; 6-8 mice/group) were tested on an accelerating rotarod (San Diego Instruments, San Diego, CA) to assess motor coordination, balance, and motor learning (Buitrago et al., 2004; Wei et al., 2011; Rong et al., 2012) . The rotarod accelerated from 0 to 40 rpm in 4 min and then maintained constant speed for 1 min. The time elapsed before the mouse fell (latency to fall) was recorded. The maximum observation time was 5 min. Animals received 2 trials per day, with a 20-min inter-trial interval for 5 consecutive days (MondayFriday; 9AM-11AM, the order in which animals were tested was randomized). Data include all tested animals, and were expressed as mean ± SEM and analyzed for statistical significance using repeated-measures analysis of variance (ANOVA). Where appropriate multiplecomparison tests were performed with Bonferroni's adjustment. The level of significance was set at p < 0.05.
Statistical analysis
Student's t-test was used unless otherwise stated. Significance was set at a p of < 0.05. All statistical analyses were performed using SAS version 9.2 (SAS Institute Inc., Cary, NC). cells were transfected with FLAG-tagged Grid1, Grid2, Nrxn1β, Nrxn3β, DCC or empty vector (mock). Cells were subsequently exposed to conditioned medium (Input) containing HA-tagged Cbln1, Cbln1 N23Q , Cbln1 N79Q ; Cbln2, Cbln2 N53Q , Cbln2 N110Q and Cbln4, Cbln4 N26Q , Cbln4
N85Q for 4 h. After washing, cells were lysed, subjected to SDS-PAGE and immunoblotted with anti-HA and anti-FLAG antisera. Quantification was performed on three independent binding assays.
(a) Cbln1 bound to Grid2, Nrxn1β, and Nrxn3β, but not to DCC. Cbln1 N23Q and notably Cbln1 N79Q had greater Grid1 (p<0.05) and Grid2 (p<0.001) binding activity than WT Cbln1.
When corrected for input, both glycosylation mutants, and notably Cbln1 N23Q , exhibited 
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